B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

GRM1

MOLECULAR TARGET

glutamate metabotropic receptor 1

UniProt: Q13255NCBI Gene: 29118 compounds

GRM1 (glutamate metabotropic receptor 1) is targeted by 8 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting GRM1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1quisqualate3.0921
2Glutamic Acid3.0019
3Glutamic Acid3.0019
4bdb whuutdbjxjrkmk2.208
5Ibotenic Acid1.102
6bdb 2 amino bicyclo 2 1 1 hexane 2 5 dicarboxylic acid abhxd i chembl905010.691
7bdb chembl24183640.691
8bdb s 2 2 adamantan 1 yl acetylamino n 3 4 3 amino propylamino butylamino propyl 3 c0.691

About GRM1 as a Drug Target

GRM1 (glutamate metabotropic receptor 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 8 compounds with documented GRM1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

GRM1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.